News

05/17/2022

Activation Capital Awarded State Grant to Develop Regional Entrepreneurship Strategy for Central Virginia

-$450,000 Committed to Using Entrepreneurship as a Means of Economic Development- Richmond, VA – Activation Capital, a leading entrepreneurship and ecosystem development organization, was awarded $300,000 from GO Virginia for Region 4’s Regional Entrepreneurship Initiative (REI).  The funding, coupled with cash and in-kind donations from Altria, Dominion Energy, Greensville County and Activation Capital will total

05/17/2022

Sam Konduros, JD, Named CEO of Southeast Life Science

Roswell, GA and Greenville, SC – The Board of Directors of Southeast Life Sciences (SLS) has named Sam Konduros, Founder and President of Greenville-based SK Strategies, as Chief Executive Officer effective June 1, 2022. Mr. Konduros succeeds Jason Rupp in the leadership role, in which Mr. Rupp served from 2019 to 2022. Mr. Rupp’s tenure

05/17/2022

Governor Youngkin Announces Expansion of Life Sciences in Prince William County, Creating up to 70 New Jobs

~ Virongy Biosciences Inc. to invest $471,000 to begin development of diagnostic technologies for viral pathogens ~ RICHMOND, VA – Governor Glenn Youngkin announced that Virongy Biosciences Inc., a developer of viral diagnostic technologies, anti-viral drugs, and therapeutic viral vectors, will invest $471,000 to expand in Prince William County. The company recently relocated to occupy over

05/11/2022

UVA Health, Focused Ultrasound Foundation Partner to Create World’s First Focused Ultrasound Cancer Immunotherapy Center

$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs Charlottesville, VA – UVA Health and the Charlottesville-based Focused Ultrasound Foundation today announced the launch of the Focused Ultrasound Cancer Immunotherapy Center, the world’s first center dedicated specifically to advancing a focused ultrasound and cancer immunotherapy treatment approach that could revolutionize 21st-century cancer

05/10/2022

Germany’s BfArM Approves ReAlta Life Sciences’ Phase 1b Study

Inhaled LPS Challenge Trial to Support Development of RLS-0071 in Severe Asthma RLS-0071 is ReAlta’s lead dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic ischemic encephalopathy, severe asthma, and other rare diseases Norfolk, VA, – ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing

05/04/2022

GRP named a top economic development organization in the U.S.

RICHMOND, VA – The Greater Richmond Partnership (GRP) was named among the top 20 economic development organizations in the nation according to Site Selection magazine, a national publication targeting site location professionals and corporate executives making relocation decisions. The 2022 Mac Conway Awards for Excellence in Economic Development, named in honor of Site Selection founding publisher